SCHEMBL4997344

SCHEMBL4997344

NC(=O)c1ccc(-c2nccc(-c3cc4n(n3)CCNC4=O)n2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC7 O00311 1/20 0.51
MAP4K4 O95819 2/20 0.48
RPS6KA3 P51812 1/20 0.42
IKBKB O14920 1/20 0.39
CHUK O15111 1/20 0.39
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
HPGD P15428 1/20 0.38
JAK2 O60674 1/20 0.37
PIM1 P11309 1/20 0.37
PIM2 Q9P1W9 1/20 0.37
MAPKAPK2 P49137 1/20 0.37
TGFB1 P01137 1/20 0.36
PRKD3 O94806 1/20 0.36
PRKD1 Q15139 1/20 0.36
PRKD2 Q9BZL6 1/20 0.36
CAMKK2 Q96RR4 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
PRNP P04156 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4991763 0.90 CDC7 (0.52) CDC7MAP4K4RPS6KA3PIM1PIM2
SCHEMBL4996859 0.89 CDC7 (0.51) CDC7MAP4K4PIM1PIM2MAPKAPK2
SCHEMBL4997425 0.88 CDC7 (0.48) CDC7RPS6KA3PIM1PIM2MAPKAPK2
SCHEMBL4995841 0.87 CDC7 (0.54) CDC7MAP4K4PIM1PIM2MAPKAPK2
SCHEMBL4991458 0.87 CDC7 (0.54) CDC7MAP4K4PIM1PIM2MAPKAPK2
SCHEMBL4991418 0.87 CDC7 (0.49) CDC7RPS6KA3JAK2PIM1PIM2
SCHEMBL4995882 0.87 CDC7 (0.49) CDC7RPS6KA3PIM1PIM2MAPKAPK2
SCHEMBL4993478 0.86 CDC7 (0.53) CDC7MAP4K4PIM1PIM2MAPKAPK2
SCHEMBL4993179 0.86 CDC7 (0.53) CDC7PIM1PIM2MAPKAPK2KDM4E
SCHEMBL4994640 0.86 CDC7 (0.48) CDC7MAP4K4RPS6KA3PIM1PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS HANAU CATHLEEN E 2008-05-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080113971-A1 PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS MKNK2, MAPKAPK2, MAP3K2 CDC7 487/4885MAP4K4 32/4885RPS6KA3 76/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.